MENU
WGRX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

WGRX stock forecast, quote, news & analysis

Wellgistics Health Inc is a healthcare technology and pharmaceutical logistics company... Show more

WGRX
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for WGRX with price predictions
Jul 10, 2026

WGRX in -3.87% downward trend, falling for three consecutive days on July 02, 2026

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where WGRX declined for three days, in of 124 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Aroon Indicator for WGRX entered a downward trend on July 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The Momentum Indicator moved above the 0 level on July 09, 2026. You may want to consider a long position or call options on WGRX as a result. In of 22 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for WGRX just turned positive on June 30, 2026. Looking at past instances where WGRX's MACD turned positive, the stock continued to rise in of 12 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where WGRX advanced for three days, in of 39 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.814) is normal, around the industry mean (1.328). P/E Ratio (0.000) is within average values for comparable stocks, (128.278). WGRX's Dividend Yield (0.000) is considerably lower than the industry average of (0.085). P/S Ratio (0.368) is also within normal values, averaging (3.787).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. WGRX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. WGRX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 100, placing this stock worse than average.

A.I.Advisor
published Highlights

Industry description

The drugstore chains industry includes stores that sell medicines (both prescription and non-prescription), health, beauty and personal care products. Over time, many pharmacy retail chains have launched their own pharmacy benefits management services. Since demand for medical products is typically less sensitive to economic cycles, drugstore retail chains industry could be largely considered as non-cyclical. CVS Health Corporation, Walgreens Boots Alliance Inc. and Rite Aid Corporation are some of the biggest operators in this industry.

Market Cap

The average market capitalization across the Drugstore Chains Industry is 51.82M. The market cap for tickers in the group ranges from 3.29K to 18.63B. JDHIF holds the highest valuation in this group at 18.63B. The lowest valued company is RLLVF at 3.29K.

High and low price notable news

The average weekly price growth across all stocks in the Drugstore Chains Industry was -4%. For the same Industry, the average monthly price growth was -4%, and the average quarterly price growth was -56%. SCNX experienced the highest price growth at 8%, while HITI experienced the biggest fall at -4%.

Volume

The average weekly volume growth across all stocks in the Drugstore Chains Industry was 540%. For the same stocks of the Industry, the average monthly volume growth was 14% and the average quarterly volume growth was 224%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 42
P/E Growth Rating: 93
Price Growth Rating: 79
SMR Rating: 86
Profit Risk Rating: 100
Seasonality Score: -31 (-100 ... +100)
View a ticker or compare two or three
WGRX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry DrugstoreChains

Profile
Details
WGRX in -3.87% downward trend, falling for three consecutive days on July 02, 2026